Internship

Global Regulatory CMC-Cell Therapy Internship

Confirmed live in the last 24 hours

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Summit, NJ, USA

Intern will be based in Summit, NJ.

Category
Bioinformatics
Biology Lab & Research
Legal & Compliance
Biology & Biotech
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • Graduate student in a Life Sciences Program such as Chemical and Biochemical Engineering, Biomedical Engineering, Molecular Biology, Biochemistry
  • Knowledge of protein synthesis, purification, characterization (SDS-PAGE, Western Blots, Elisa, etc.)
  • Knowledge of cell culture, cell-based assays, flow cytometry is strongly desired
  • Attention to detail, excellent organization skills, good verbal and written communication skills are required.
  • Ability to work independently on routine assignments with daily check-ins and to work cooperatively with senior staff providing key assistance on complex assignment
  • Computer experience must include familiarity with Word, Excel and PowerPoint
Responsibilities
  • Support Regulatory CMC Cell Therapy group in the preparation of CMC Regulatory Strategy and submissions and interactions with Global Health Authorities.
  • Attend and participate in various Reg CMC and matrix team meetings as needed and applicable
  • Manage and prioritize multiple complex projects

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet the same quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, as well as its commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing access to effective and affordable healthcare solutions.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.

Help us improve and share your feedback! Did you find this helpful?